We interviewed David E. Olson, Director of the UC Davis Institute for Psychedelics and Neurotherapeutics and Co-Founder of Delix Therapeutics, to discuss zalsupindole and the next generation of neuroplastogens: compounds designed to promote lasting neural plasticity without hallucinogenic effects. Join us as we explore how these molecules are reshaping psychiatry’s future.